Synlogic announces participation in svb securities healthcare therapeutics forum

Cambridge, mass., june 27, 2023 (globe newswire) -- synlogic, inc. (nasdaq: sybx), a clinical-stage biotechnology company advancing novel, oral, non-systemically absorbed biotherapeutics to transform the care of serious diseases, today announced that its management team will participate in the svb securities healthcare therapeutics forum, being held in new york, july 11-12, 2023. the synlogic team will be available for one-on-one investor meetings. to register for the conference or request one-on-one meetings, please contact your svb securities representative.
SYBX Ratings Summary
SYBX Quant Ranking